RecruitingNCT05479448

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Basel, Switzerland
Principal Investigator
Thomas Daikeler, Prof. Dr. med.
Department of Rheumatology University Hospital Basel
Intervention
Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)(other)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2028

Study locations (1)

Collaborators

Schweizerische Stiftung für die Erforschung der Muskelkrankheiten · Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05479448 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis →

← Back to all trials